The coexpression of ERα and ERβ was more prevalent in chronic liver disease compared to HCC, and elevated expression of ERα or splice variants, as well as lower intact ERβ, was found more often in those with severe liver disease and HCC (99). Here, ESR2 is linked to hepatocellular carcinoma.